معرفی
Dr. Alan Abdulla is a Researcher at the Erasmus University Medical Center in Rotterdam, Netherlands. His academic career has focused on pharmacokinetic/pharmacodynamic (PK/PD) modeling of antibiotics in critically ill patients, with particular emphasis on therapeutic drug monitoring (TDM) and individualized dosing strategies.
- PhD (2018-2022) in Dose individualization of Beta-lactams and Ciprofloxacin in ICU patients
- Post-doctoral position since 2018
- Previous residency (2013-2017) and hospital pharmacy experience
His research integrates clinical pharmacology, intensive care medicine, and pediatric antibiotic therapy. Key projects include:
- 2025: Optimizing ceftriaxone models in pediatrics (€150K MRace Grant)
- 2022: Multi-center randomized trial on beta-lactam dosing (€500K ZonMw funding)
- 2021: Population pharmacokinetics in children (€50K Stichting de Merel)
Notable scientific recognitions:
- 2018 Best Abstract Award - Residents association (AAV Erasmus MC)
- 2017 Best Abstract Oral Presentation - Dutch Association for Intensive Care
- 2019 Best publication award - Dutch Platform for Pharmaceutical Research
His work addresses both broad clinical implementation challenges and specific pharmacometric questions in antibiotic therapy, with teaching activities including supervision of MSc Pharmacy and Medical student thesis projects.
۰مقاله منتشرشده
Alan Abdulla در سایتهای دیگر
جستوجوهای مرتبط
شاید اینها هم برایتان مناسب باشند
- AAlan AbdullaErasmus University Rotterdam · پژوهشگر
Menino Osbert CottaUniversity of Queensland · پژوهشگر ارشد- SStef SchouwenburgErasmus University Rotterdam · پژوهشگر
- NNicole HunfeldErasmus University Rotterdam · پژوهشگر
- BBirgit KochErasmus University Rotterdam · استاد
Mohd Hafiz Abdul-AzizUniversity of Queensland · پژوهشگر ارشد